BILL OF SALEBill of Sale • December 28th, 2023 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations
THIS BILL OF SALE (this “Bill of Sale”) is dated as of this 27th day of December, 2023, by NEUBASE THERAPEUTICS, INC., a Delaware corporation (the “Transferor”) for the benefit of UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, a Pennsylvania non-profit corporation (the “Transferee”).
LEASE TERMINATION AND MUTUAL RELEASE AGREEMENTLease Termination and Mutual Release Agreement • December 28th, 2023 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations
THIS LEASE TERMINATION AND MUTUAL RELEASE AGREEMENT (this “Agreement”) is made as of this 27 day of December, 2023 (the “Effective Date”), by and between 350 TECHNOLOGY DRIVE PARTNERS, LLC, a Pennsylvania limited liability company (“Landlord”), and NEUBASE THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
